APA (7th ed.) Citation

S, S., T, B., C, W., C, T., I, L., NP, Q., . . . Y, S. (2025). Lymphodepleting chemotherapy potentiates neoantigen-directed T cell therapy by enhancing antigen presentation. Cell reports. Medicine, 6(12), 102506. https://doi.org/10.1016/j.xcrm.2025.102506

Chicago Style (17th ed.) Citation

S, Sagie, et al. "Lymphodepleting Chemotherapy Potentiates Neoantigen-directed T Cell Therapy by Enhancing Antigen Presentation." Cell Reports. Medicine 6, no. 12 (2025): 102506. https://doi.org/10.1016/j.xcrm.2025.102506.

MLA (9th ed.) Citation

S, Sagie, et al. "Lymphodepleting Chemotherapy Potentiates Neoantigen-directed T Cell Therapy by Enhancing Antigen Presentation." Cell Reports. Medicine, vol. 6, no. 12, 2025, p. 102506, https://doi.org/10.1016/j.xcrm.2025.102506.